Hospital trial aims to stop deadly c. diff before it starts
NCT ID NCT05389904
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests a prevention bundle for hospital patients who carry C. difficile bacteria but have no symptoms. The bundle includes enhanced room cleaning and special precautions. Researchers hope to prevent these carriers from developing active infections and spreading the bacteria to others. The study enrolls 300 patients in ICU or oncology units.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- prevention bundle (enhanced cleaning, precautions)
- What this could lead to
- If it works, this could reduce hospital-acquired C. difficile infections and deaths by catching carriers early.
- What could go wrong
- This is a small, early-stage trial (300 patients) testing a bundle of measures, not a new drug. Results may not apply to all hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for C. DIFFICILE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States